Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene

United States News News

Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene
United States Latest News,United States Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said.

Bristol-Myers Squibb CEO Giovanni Caforio told CNBC on Friday the company is"one step closer to creating that great company" after shareholders greenlit a $74 billion takeover of Celgene.

"When the two companies come together, we'll have two growing businesses," Caforio said in an interview with "Mad Money's" Jim Cramer."We're going to be able to launch six new medicines, potentially, in the next two years. It's going to be a great company, [will] create value for shareholders, [and will be] very good for patients."

Celgene is also a leader, he added, in treatments for multiple myeloma, a cancer that attacks the plasma cells that create antibodies to fight infections.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol-Myers shareholders approve drugmaker's $74 billion deal with CelgeneBristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Read more »

Bristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers Squibb Co's shareholders voted to approve the drugmaker'...
Read more »

Bristol-Myers shareholders approve drugmaker's $74 billion deal with CelgeneBristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Read more »

Bristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers Squibb Co's shareholders voted to approve the drugmaker'...
Read more »

Here’s one way to tell if a company is overpaying its CEOHere’s one way to tell if a company is overpaying its CEOU.S. companies that use non-standard numbers to calculate executive compensation are overpaying their top managers, according to a new research report.
Read more »

Disney CEO Bob Iger says he will step down in 2021, a succession plan is formingDisney CEO Bob Iger says he will step down in 2021, a succession plan is formingDisney CEO Bob Iger said that he is definitely stepping down from his post at the company in 2021.
Read more »

Exclusive: Trump eyeing stepped-up Venezuela sanctions for foreign companies - BoltonExclusive: Trump eyeing stepped-up Venezuela sanctions for foreign companies - BoltonWATCH: Trump is eyeing 'secondary sanctions' on Venezuela that would hit companies from other countries who do business with Maduro's government, national security adviser Bolton said
Read more »

Disney CEO Iger gives three reasons why the company's streaming service will be a successDisney CEO Iger gives three reasons why the company's streaming service will be a successDisney Chairman and CEO Bob Iger explained that he believes customers will flock to Disney+ thanks to a combination of unique factors.
Read more »



Render Time: 2025-02-26 01:16:48